Inventors:
Olga Bandman - Mountain View CA, US
Danniel B Nguyen - San Jose CA, US
Narinder K Chawla - Union City CA, US
April J A Hafalia - Santa Clara CA, US
Monique G Yao - Carmel IN, US
Ameena R Gandhi - San Francisco CA, US
Rajagopal Gururajan - San Jose CA, US
Li Ding - Creve Coeur MO, US
Chandra S Arvizu - San Jose CA, US
Henry Yue - Sunnyvale CA, US
Mariah R Baughn - San Leandro CA, US
Catherine M Tribouley - San Francisco CA, US
Michael B Thornton - Oakland CA, US
Vicki S Elliott - San Jose CA, US
Yan Lu - Palo Alto CA, US
Craig H Ison - San Jose CA, US
Janice K Au-Young - Brisbane CA, US
Y Tom Tang - San Jose CA, US
Yalda Azimzai - Oakland CA, US
John D Burrill - Redwood City CA, US
Gregory A Marcus - San Carlos CA, US
Kurt A Zingler - San Francisco CA, US
Dyung Aina M Lu - San Jose CA, US
Preeti G Lai - Santa Clara CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Bridget A Warren - Encinitas CA, US
Liam Kearney - San Francisco CA, US
Jennifer L Policky - San Jose CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Neil Burford - Durham CT, US
Assignee:
Incyte Corporation - Wilmington DE
International Classification:
C12N 15/54
C12N 9/12
US Classification:
435194, 435325, 4353201, 4352523, 536 232
Abstract:
The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.
